A high and equal prevalence of the Q703K variant in NLRP3 patients with autoinflammatory symptoms and ethnically matched controls.
Merav Lidar(Sheba Medical Center), Elon Pras(Tel Aviv University), Haike Reznik‐Wolf(Tel Aviv University), Yackov Berkun(Hadassah Medical Center), Ilan Ben Zvi(Sheba Medical Center), Hagit Peleg(Hadassah Medical Center), Michael Rozenbaum(Bnai Zion Medical Center), Yael Brantz(Sheba Medical Center), Rinat Cohen(Sheba Medical Center), Avi Livneh(Sheba Medical Center), Aharon Kessel(Technion – Israel Institute of Technology), Ofra Goldzweig(Kaplan Medical Center), Philip J. Hashkes(Shaare Zedek Medical Center), Yael Shinar(Sheba Medical Center), Gleb Slobodin(Bnai Zion Medical Center)
PubMed
February 13, 2018
Cited by 5
Related Papers
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
EULAR recommendations for the management of familial Mediterranean fever
|Annals of the Rheumatic Diseases|2016|593
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
|Journal of Clinical Investigation|2018|519